According to the company's own fine-print disclosures, results described on the website are based on self-reported data
Lancet 372(9645):12401250 [DOI] [PubMed] [Google Scholar] Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits
Over the past few years, several effective anti-obesity medications have been introduced, particularly for people who fail to lose weight with conservative measures alone
Schedule a consultation to discuss GLP-1 weight loss options with Dr
Retatrutides mechanism of action Retatrutides mechanism of action combines the effects of three hormones naturally produced after eating: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon
Retatrutide is an investigational medication currently undergoing clinical trials for the management of obesity and type 2 diabetes